Public Alert No. 052/2024 – Alert of Confirmed Cases of Two Counterfeit Batches of Avastin 400mg/16ml, Manufactured By Roche Diagnostics Public Gmbh, Mannheim, Germany
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of two confirmed cases of two batches of counterfeit AVASTIN 400mg/16ml with batch number H0223B08 and H4239A70 in Nigeria. H0223B08 The Marketing Authorization Holder (MAH) Roche notified the Agency that a pharmacist reported the purchase of the counterfeited Avastin Vials […]
Public Alert No. 051/2024 -Alert on Confirmed Counterfeit PHESGO 600mg600mg/10ml With Batch Number C5290S20 Stated to be Manufactured by Roche S,P,A.
The National Agency for Food and Drugs Administration and Control (NAFDAC) wishes to inform healthcare providers and the public of a report of a suspected counterfeit Phesgo® 600mg/600mg/10ml, labeled with batch C5290S20. The Marketing Authorization Holder (MAH) Roche received a complaint from a doctor at Lagos University Teaching Hospital (LUTH-NSIA) reporting a suspected counterfeit Phesgo® 600mg/600mg, […]
Public Alert No. 050/2024 -Alert on the Recall of Apo-Amitriptyline 10mg and 25mg Manufactured by Pharma Forte Singapore Pte Ltd.
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public that the Health Sciences Authority (HAS) of Singapore has announced the recall of eight (8) batches of Apo-Amitriptyline 10mg and three (3) batches of Apo-Amitriptyline 25mg tablets, manufactured by Pharma Forte Singapore Pte Ltd. The affected batches were recalled due […]
